Bioequivalence studies for GCC submission [Design Issues]

posted by drgunasakaran1  – 2025-01-31 04:20 (153 d 07:49 ago) – Posting: # 24354
Views: 1,712

❝ Would it be acceptable to conduct bioequivalence studies for GCC submission at CRO if the facility has already been inspected by the US FDA? We don’t have separate GCC facility approval.

If the CRO has been approved in the last two years by two of the following drug regulatory agencies such as US FDA, Health Canada, TGA - Australia, UK MHRA, EMA, or WHO, along with one additional authority from the list, then you can include CRO name in the list of bioequivalence centers approved by GCC and you can conduct studies for GCC submission.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,683 registered users;
43 visitors (0 registered, 43 guests [including 13 identified bots]).
Forum time: 13:10 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5